메뉴 건너뛰기




Volumn 18, Issue 7, 2017, Pages 735-738

Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis

Author keywords

clinical trial; motor neuron; nitric oxide; Oxidative stress; radical scavenger

Indexed keywords

3 NITROTYROSINE; NORPHENAZONE; RILUZOLE; 3-NITROTYROSINE; PHENAZONE; PHENYLMETHYLPYRAZOLONE; SCAVENGER; TYROSINE;

EID: 85018869033     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1080/14656566.2017.1319937     Document Type: Article
Times cited : (111)

References (27)
  • 1
    • 84914677322 scopus 로고    scopus 로고
    • Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
    • Abe K, Itoyama Y, Sobue G, et al. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:610–617.• This paper reports the results of double blind placebo-controlled trial of edaravone against ALS (MCI186-16) with negative results.
    • (2014) Amyotroph Lateral Scler Frontotemporal Degener , vol.15 , pp. 610-617
    • Abe, K.1    Itoyama, Y.2    Sobue, G.3
  • 2
    • 85018860386 scopus 로고    scopus 로고
    • A 24-week, phase III, double-blind, parallel-group study of edaravone (MCI-186) for treatment of amyotrophic lateral sclerosis (ALS)
    • Tanaka M, Sakata T, Palumbo J,MA., A 24-week, phase III, double-blind, parallel-group study of edaravone (MCI-186) for treatment of amyotrophic lateral sclerosis (ALS). Neurology. 2015;86:S189.•• This paper reports summary results of an RCT of edaravone against ALS (MCI186-19). In this summary it provides significant efficacy in ALS.
    • (2015) Neurology , vol.86 , pp. S189
    • Tanaka, M.1    Sakata, T.2    Palumbo, J.M.A.3
  • 3
    • 33847119443 scopus 로고    scopus 로고
    • Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study)
    • Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). Amyotroph Lateral Scler. 2006;7:241–245.
    • (2006) Amyotroph Lateral Scler , vol.7 , pp. 241-245
    • Yoshino, H.1    Kimura, A.2
  • 4
    • 0032731637 scopus 로고    scopus 로고
    • ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis
    • Kruman II, Pedersen WA, Springer JE, et al. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol. 1999;160(1):28–39.
    • (1999) Exp Neurol , vol.160 , Issue.1 , pp. 28-39
    • Kruman, I.I.1    Pedersen, W.A.2    Springer, J.E.3
  • 5
    • 0036391077 scopus 로고    scopus 로고
    • Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress
    • Cookson MR, Menzies FM, Manning P, et al. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:75–85.
    • (2002) Amyotroph Lateral Scler Other Motor Neuron Disord , vol.3 , pp. 75-85
    • Cookson, M.R.1    Menzies, F.M.2    Manning, P.3
  • 6
    • 0002770493 scopus 로고    scopus 로고
    • Superoxide dismutase and the death of motoneurons in ALS
    • Beckman JS, Estevez AG, Crow JP, et al. Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci. 2001;24(11 Suppl):S15–20.
    • (2001) Trends Neurosci , vol.24 , Issue.11 , pp. S15-S20
    • Beckman, J.S.1    Estevez, A.G.2    Crow, J.P.3
  • 8
    • 79955812764 scopus 로고    scopus 로고
    • TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology
    • Wegorzewska I, Baloh RH. TDP-43-based animal models of neurodegeneration:new insights into ALS pathology and pathophysiology. Neurodegener Dis. 2011;8:262–274.
    • (2011) Neurodegener Dis , vol.8 , pp. 262-274
    • Wegorzewska, I.1    Baloh, R.H.2
  • 9
    • 75149155060 scopus 로고    scopus 로고
    • Oxidative stress in ALS: key role in motor neuron injury and therapeutic target
    • Barber SC, Shaw PJ. Oxidative stress in ALS:key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010;48:629–641.
    • (2010) Free Radic Biol Med , vol.48 , pp. 629-641
    • Barber, S.C.1    Shaw, P.J.2
  • 10
    • 0033009113 scopus 로고    scopus 로고
    • Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis
    • Tohgi H, Abe T, Yamazaki K, et al. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol. 1999;46:129–131.
    • (1999) Ann Neurol , vol.46 , pp. 129-131
    • Tohgi, H.1    Abe, T.2    Yamazaki, K.3
  • 11
    • 0029923226 scopus 로고    scopus 로고
    • Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation
    • Shimohama S, Akaike A, Kimura J. Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. Ann NY Acad Sci. 1996;777:356–361.
    • (1996) Ann NY Acad Sci , vol.777 , pp. 356-361
    • Shimohama, S.1    Akaike, A.2    Kimura, J.3
  • 12
    • 0030065222 scopus 로고    scopus 로고
    • Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon
    • Sawada H, Shimohama S, Tamura Y, et al. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon. J Neurosci Res. 1996;43:55–62.
    • (1996) J Neurosci Res , vol.43 , pp. 55-62
    • Sawada, H.1    Shimohama, S.2    Tamura, Y.3
  • 13
    • 0032856942 scopus 로고    scopus 로고
    • MPP(+) and glutamate in the degeneration of nigral dopaminergic neurons
    • Sawada H, Shimohama S. MPP(+) and glutamate in the degeneration of nigral dopaminergic neurons. Parkinsonism Relat Disord. 1999;5:209–215.
    • (1999) Parkinsonism Relat Disord , vol.5 , pp. 209-215
    • Sawada, H.1    Shimohama, S.2
  • 14
    • 0031795392 scopus 로고    scopus 로고
    • Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection
    • Urushitani M, Shimohama S, Kihara T, et al. Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate:involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection. Ann Neurol. 1998;44:796–807.
    • (1998) Ann Neurol , vol.44 , pp. 796-807
    • Urushitani, M.1    Shimohama, S.2    Kihara, T.3
  • 15
    • 0035283075 scopus 로고    scopus 로고
    • N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx
    • Urushitani M, Nakamizo T, Inoue R, et al. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death:a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. J Neurosci Res. 2001;63:377–387.
    • (2001) J Neurosci Res , vol.63 , pp. 377-387
    • Urushitani, M.1    Nakamizo, T.2    Inoue, R.3
  • 16
    • 0031473081 scopus 로고    scopus 로고
    • Abnormal dephosphorylation effect on NMDA receptor regulation in ALS spinal cord
    • Wagey R, Krieger C, Shaw CA. Abnormal dephosphorylation effect on NMDA receptor regulation in ALS spinal cord. Neurobiol Dis. 1997;4:350–355.
    • (1997) Neurobiol Dis , vol.4 , pp. 350-355
    • Wagey, R.1    Krieger, C.2    Shaw, C.A.3
  • 17
    • 0030888919 scopus 로고    scopus 로고
    • Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis
    • Abe K, Pan LH, Watanabe M, et al. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res. 1997;19:124–128.
    • (1997) Neurol Res , vol.19 , pp. 124-128
    • Abe, K.1    Pan, L.H.2    Watanabe, M.3
  • 18
  • 19
    • 84978726307 scopus 로고    scopus 로고
    • Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone
    • Fujisawa A, Yamamoto Y. Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone. Redox Rep. 2016;21:98–103.
    • (2016) Redox Rep , vol.21 , pp. 98-103
    • Fujisawa, A.1    Yamamoto, Y.2
  • 20
    • 84978698157 scopus 로고    scopus 로고
    • Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration
    • Nagase M, Yamamoto Y, Miyazaki Y, et al. Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration. Redox Rep. 2016;21:104–112.
    • (2016) Redox Rep , vol.21 , pp. 104-112
    • Nagase, M.1    Yamamoto, Y.2    Miyazaki, Y.3
  • 21
    • 84878937019 scopus 로고    scopus 로고
    • Edaravone ameliorates oxidative damage associated with Abeta25-35 treatment in PC12 cells
    • Zhang GL, Zhang WG, Du Y, et al. Edaravone ameliorates oxidative damage associated with Abeta25-35 treatment in PC12 cells. J Mol Neurosci. 2013;50:494–503.
    • (2013) J Mol Neurosci , vol.50 , pp. 494-503
    • Zhang, G.L.1    Zhang, W.G.2    Du, Y.3
  • 22
    • 34250730257 scopus 로고    scopus 로고
    • Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum
    • Kawasaki T, Ishihara K, Ago Y, et al. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. J Pharmacol Exp Ther. 2007;322:274–281.
    • (2007) J Pharmacol Exp Ther , vol.322 , pp. 274-281
    • Kawasaki, T.1    Ishihara, K.2    Ago, Y.3
  • 23
    • 51549119688 scopus 로고    scopus 로고
    • Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice
    • Ito H, Wate R, Zhang J, et al. Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice. Exp Neurol. 2008;213:448–455.
    • (2008) Exp Neurol , vol.213 , pp. 448-455
    • Ito, H.1    Wate, R.2    Zhang, J.3
  • 24
    • 84949035818 scopus 로고    scopus 로고
    • Edaravone, a free radical scavenger, delayed symptomatic and pathological progression of motor neuron disease in the wobbler mouse
    • Ikeda K, Iwasaki Y. Edaravone, a free radical scavenger, delayed symptomatic and pathological progression of motor neuron disease in the wobbler mouse. PLoS One. 2015;10:e0140316.
    • (2015) PLoS One , vol.10 , pp. e0140316
    • Ikeda, K.1    Iwasaki, Y.2
  • 25
    • 79952537198 scopus 로고    scopus 로고
    • Feasibility study for functional test battery of SOD transgenic rat (H46R) and evaluation of edaravone, a free radical scavenger
    • Aoki M, Warita H, Mizuno H, et al. Feasibility study for functional test battery of SOD transgenic rat (H46R) and evaluation of edaravone, a free radical scavenger. Brain Res. 2011;1382:321–325.
    • (2011) Brain Res , vol.1382 , pp. 321-325
    • Aoki, M.1    Warita, H.2    Mizuno, H.3
  • 27
    • 85018908921 scopus 로고    scopus 로고
    • Phase I trial of MCI-186 (edaravone)
    • Shibata H, Arai S, Isawa M, et al. Phase I trial of MCI-186 (edaravone). Jpn J Clin Pharmacol. 1998;29:864–876.
    • (1998) Jpn J Clin Pharmacol , vol.29 , pp. 864-876
    • Shibata, H.1    Arai, S.2    Isawa, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.